FDA Indication Extrapolations-Allowing Flexibility While Providing Greater Clarity
JAMA Netw Open
.
2022 Apr 1;5(4):e227961.
doi: 10.1001/jamanetworkopen.2022.7961.
Authors
Reshma Ramachandran
1
2
,
Joseph S Ross
1
3
4
5
Affiliations
1
National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
2
Veterans Affairs Connecticut Healthcare System and Yale University, West Haven, Connecticut.
3
Section of General Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
4
Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.
5
Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, Connecticut.
PMID:
35438761
DOI:
10.1001/jamanetworkopen.2022.7961
No abstract available
Publication types
Comment
MeSH terms
Humans
United States
United States Food and Drug Administration*